Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Virtual reality may ease cancer Patients' scan anxiety

NCT ID NCT05269186

Symptom relief Sponsor: Centre Hospitalier Departemental Vendee Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a 20-minute virtual reality session before a planning CT scan could lower anxiety in 256 breast or pelvic cancer patients starting radiotherapy. Patients were randomly assigned to either the VR session or usual care. The goal was to see if VR could reduce anxiety levels measured by a standard questionnaire, offering a low-cost, low-staff alternative to other relaxation methods.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
virtual reality software
What this could lead to
If it works, this could offer a simple, non-drug way to help cancer patients feel less anxious before their radiotherapy planning scan.
What could go wrong
This is a completed, moderate-sized trial, but it only measured anxiety before one scan, not during full treatment. The effect may be small or not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

256 people

The number who actually took part.

Started

Oct 2022

Finished

Jul 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 84 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Patient with an indication for first radiotherapy treatment for breast or pelvic cancer (prostate, rectum, endometrium, anal canal and cervix) 2. Patient ≥ 18 years old, 3. Patient who has the capacity to understand the protocol and has given written consent to participate in the research, 4. Patient with social security coverage. Exclusion Criteria: 1. Metastatic patients 2. Patients with previous radiotherapy 3. Patients with a diagnosis of hearing impairment 4. Patients with major cognitive disorders (such as dementia) 5. Psychiatric pathology such as schizophrenia 6. Patients with epilepsy or hypersensitivity to flashing lights 7. Patient with a pacemaker, hearing aid or defibrillator 8. Claustrophobic patients 9. Patients sensitive to motion sickness 10. Patients who are visually impaired or blind 11. Patients with migraine 12. Patients with skin defects and open wounds in the area where the helmet is applied (face or scalp) or in the eyes 13. Patients under guardianship, curators or deprived of liberty 14. Non French speaking patient 15. Illiterate patient 16. Patient participating in another clinical investigation or interventional clinical research protocol involving a drug 17. Pregnant or breastfeeding patient

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Breast cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm Pelvic Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Breast cancer Pelvic cancer

Contacts and locations

Locations

  • CHD Vendée

    La Roche-sur-Yon, 85000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.